Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cyclosporin A in atopic dermatitis].

Miguel Angel Cordero Miranda1, Begonia Casas Becerra, Norma Isabel Reyes Ruiz

  • 1Servicio de alergia, Médico pediatra, Hospital Infantil de México Federico Gómez, México, DF.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|October 11, 2002
PubMed
Summary

Cyclosporine effectively manages severe atopic dermatitis (AD) by suppressing T cells. This treatment reduces disease markers and balances immune responses, with careful dosing to minimize side effects like renal toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and Outcomes of Cases of Children and Adolescents With Pediatric Inflammatory Multisystem Syndrome in a Tertiary Care Center in Mexico City.

Frontiers in pediatrics·2022
Same author

Pediatric asthma treatment: What to do when international guideline recommendations do not agree.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2018
Same author

Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects: Rome, Italy/Vatican City. 27-29 April 2017.

The World Allergy Organization journal·2018
Same author

Abnormality of adipokines and endothelial dysfunction in Mexican obese adolescents with insulin resistance.

Endocrine research·2017
Same author

[Food allergy].

Gaceta medica de Mexico·2012
Same author

[Diagnosis and treatment in the emergency room of acute asthma in childhood].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2010

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Context:

  • Atopic dermatitis (AD) is a chronic, inherited inflammatory skin condition.
  • Mild AD is managed with moisturizers and topical steroids.
  • Severe cases require alternative treatments, including immunosuppressors.

Purpose:

  • To evaluate the efficacy and safety of cyclosporine in treating atopic dermatitis.
  • To determine optimal dosing strategies for cyclosporine in AD management.
  • To understand the immunological effects of cyclosporine in AD patients.

Summary:

  • Cyclosporine, an immunosuppressant, inhibits T-activated cells, showing promise in severe AD.
  • Recommended dosing involves an initial 5-6 mg/kg/day, adjusted for response (load and maintenance doses).

Related Experiment Videos

  • Immunological changes include reduced eosinophils, E-selectin, and soluble CD30, correcting Th1/Th2 imbalance.

    • Impact:

    • Cyclosporine offers an effective alternative for severe atopic dermatitis unresponsive to standard therapies.
    • Long-term management with dose adjustment aims for remission and limits adverse effects like renal toxicity and hypertension.
    • Treatment modulates key immune markers and restores immune balance in AD patients.